Por: NBC News Science February 24, 2023
An experimental nasal vaccine provided strong protection against Covid infection, according to preliminary results from a Phase 1 clinical trial. The vaccine, developed by a startup called Blue Lake Biotechnology Inc., was found to reduce the risk of symptomatic Covid infections by 86% for three months in people who received it as a booster dose. Existing booster shots in the United States reduce symptomatic infections by 43% in people 65 and... + full article
ABC7 USA Health December 25, 2022
LOS ANGELES (KABC) -- There's been a lot of confusion over COVID-19 shots and boosters regarding how many you need and when you need them.The Centers for Disease Control and Prevention said all Americans over 12 should receive the new booster against omicron, but so far,... + más
Nasal COVID vaccine blows clinical trial, flinging researchers back to the lab | Ars Technica
Without a nasal vaccine, the U.S. edge in fighting Covid is on the line | Politico
The Boston Globe USA Nation November 19, 2022
Operation Warp Speed, the Trump-era program that poured billions of dollars into developing COVID shots, seemed to signal a new dawn of American vaccine making, demonstrating how decades of scientific grunt work could be turned into lifesaving medicine in a matter of months.But... + más
Time Warp Brought The Heat To Brooklyn | Forbes
The End of Vaccines at ‘Warp Speed’ | The New York Times
The New York Times USA Health November 18, 2022
Operation Warp Speed, the Trump-era program that poured billions of dollars into developing Covid shots, seemed to signal a new dawn of American vaccine making, demonstrating how decades of scientific grunt work could be turned into lifesaving medicine in a matter of months.But... + más
The end of American-made vaccines at ‘warp speed’ | The Boston Globe
Time USA Health October 31, 2022
The U.S. led the world in quickly developing COVID-19 vaccines—one of the few bright spots in the country’s otherwise criticized response. But while injectable vaccines are effective in protecting people from getting sick with COVID-19, they are less able to block infection.... + más
Politico USA Health October 15, 2022
Biden administration officials are raising concerns that the slow pace of developing a nasal vaccine for Covid-19 in the U.S. could pose a security risk as China, Iran and Russia approve their own vaccines taken through the nose or mouth. Though nasal and oral vaccines are being... + más
Nasal COVID vaccine fails to offer desired protection in testing | The Hill
The Hill USA Health October 12, 2022
A recent clinical trial has found less-than-promising results for a nasally administered version of AstraZeneca’s COVID-19 vaccine, with immune responses observed in only “a minority of participants.” University of Oxford researchers that not only were antibody responses... + más
Ars Technica USA Science October 12, 2022
Navigate Filter by topic Settings Front page layout Site theme Comment activity Sign up or login to join the discussions! Sign up to comment and more - Oct 12, 2022 5:17 pm UTC / A man receives an H1N1 nasal flu spray vaccine at an urgent care center on October 16, 2009, in Lake... + más
Fintech Company Greenphire Wants To Make Clinical Trials More Representative Of Every Person, From All Backgrounds And Abilities | Forbes
About iurex | Privacy Policy | Disclaimer |